Market revenue in 2023 | USD 4,758.7 million |
Market revenue in 2030 | USD 9,469.0 million |
Growth rate | 10.3% (CAGR from 2023 to 2030) |
Largest segment | Glucose testing |
Fastest growing segment | Glucose testing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Glucose testing, A1C testing, Direct LDL testing, Lipid panel testing, Prostate-specific antigen testing, COVID-19 testing, BUN testing, Vitamin D testing, Thyroid-stimulating hormone testing, Serum Nicotine / Cotinine testing, High sensitivity CRP testing, Testosterone testing, ALT testing, Cortisol testing, Creatinine testing, AST testing, Other blood tests |
Key market players worldwide | Abbott Laboratories, Roche Holding AG ADR, Bio-Rad Laboratories Inc, BioMerieux SA, Quest Diagnostics Inc, Biomerica Inc, Becton Dickinson & Co, Siemens Healthineers AG ADR, Danaher Corp, Trinity Biotech PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood testing market will help companies and investors design strategic landscapes.
Glucose testing was the largest segment with a revenue share of 15.21% in 2023. Horizon Databook has segmented the China blood testing market based on glucose testing, a1c testing, direct ldl testing, lipid panel testing, prostate-specific antigen testing, covid-19 testing, bun testing, vitamin d testing, thyroid-stimulating hormone testing, serum nicotine / cotinine testing, high sensitivity crp testing, testosterone testing, alt testing, cortisol testing, creatinine testing, ast testing, other blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
China held the largest market share in 2020 owing to steady economic improvement, greater health awareness, rise in per capita disposable income, increase in healthcare expenditure, and rise in the prevalence of non-communicable diseases.
Various initiatives have been undertaken by government and nongovernment organizations to create awareness about the treatment options for these disorders. For instance, the CDC has initiated a project for reducing the consumption of sodium and tobacco to prevent COPD and cardiac disorders in China.
Governing authorities, including the State Council, have introduced policies to support the medical equipment industry of China. Engagement of companies such as Jiangsu Yuyue Medical Equipment & Supply and Hunan China Sun has intensified the competition in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the China blood testing market , including forecasts for subscribers. This country databook contains high-level insights into China blood testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account